Abkyu Enters Strategic Discovery Agreement with Synap Bio to Identify and Develop Novel VHH Clinical Assets

WATERTOWN, Mass., June 22, 2026 — Abkyu, Inc. today announced a strategic discovery agreement with Synap Biotech under which Synap  will nominate therapeutic targets and Abkyu will apply its proprietary VHH discovery platform to identify, engineer, and develop the resulting clinical assets. The arrangement is designed to give Synap a direct pipeline into Abkyu’s discovery […]